help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Genti-Raimondi, S.
Right arrow Articles by Flury, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Genti-Raimondi, S.
Right arrow Articles by Flury, A.

Journal of Clinical Endocrinology & Metabolism, Vol 76, 108-111, Copyright © 1993 by Endocrine Society

ARTICLES

Low aromatase activity in microsomes from complete hydatidiform mole

S Genti-Raimondi, CI Alvarez, LC Patrito and A Flury
Departamento de Bioquimica Clinica, Facultad de Ciencias Quimicas, Universidad Nacional de Cordoba, Argentina.

The complete hydatidiform mole (CHM) is characterized by the presence of aberrant placenta, with hyperplasia of cyto- and syncytiotrophoblasts and the absence of maternal genetic information. Steroidogenesis in this condition is, thus, of special interest. In this study we investigated the kinetic parameters of aromatase in microsomes from CHM compared with those in normal early placenta (NEP). The enzyme activity was determined by measuring the conversion of [3H] testosterone to [3H]estradiol plus [3H]estrone. The Km value for testosterone was 33 nmol/L in CHM and 17 nmol/L in NEP of similar gestational ages. Aminoglutethimide, a nonsteroidal inhibitor, decreased in a dose-dependent manner and with the same potency the aromatization of testosterone in both tissues (ID50, 2 vs. 1 mumol/L in CHM and NEP, respectively). These results suggest that the enzymes from the two sources are kinetically similar. However, the enzyme efficiency, expressed as the maximum velocity/Km ratio, was 17-fold lower in CHM than in NEP tissue (1.22/33 vs. 10.68/17 min/mg.mL). These findings suggest that in molar pregnancy the decreased capacity of trophoblast tissue for the formation of estrogen could increase the testosterone concentration inside the molar vesicle, which, in turn, as we previously reported, inhibits progesterone formation. All of these data could provide an explanation for the low circulating level of progesterone, which may directly or indirectly affect the spontaneous expulsion of this aberrant tissue in the second trimester of pregnancy.


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
J. G. Blanco, R. R. Gil, J. L. Bocco, T. L. Meragelman, S. Genti-Raimondi, and A. Flury
Aromatase Inhibition by an 11,13-Dihydroderivative of a Sesquiterpene Lactone
J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1099 - 1105.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
C. I. Dumur, N. P. Koritschoner, A. Flury, G. Panzetta-Dutari, J. L. Bocco, and L. C. Patrito
Differential Expression of a Tumor Necrosis Factor Receptor-Related Transcript in Gestational Trophoblastic Diseases in Women
Biol Reprod, July 1, 1998; 59(3): 621 - 625.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society